Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Water | HCID 962 | — |
| Reactant | tert-Butanol | HCID 6386 | — |
| Reactant | Methyl morpholine oxide | HCID 82029 | — |
| Reactant | HCID 86718927 | HCID 86718927 | — |
| Catalyst | Osmium Tetroxide | HCID 30318 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | HCID 71062432 | HCID 71062432 | 70% |
Reaction Steps
To a solution of 4-(1-(4-(allyloxy)phenyl)-5-butyl-3-(hydroxymethyl)-1H-pyrazol-4-yl)-N-(naphthalen-2-ylsulfonyl)-3-(1,2,3,4-tetrahydroisoquinoline-2-carbonyl)benzamide (Example 246, 30 mg, 0.040 mmol) in tert-BuOH (1 mL), THF (0.3 mL), and water (0.1 mL) at 0° C. was added NMO (5.6 mg, 0.048 mmol) followed by osmium tetroxide (0.062 mL, 7.9 mmol, 4 wt %). After stirring at room temperature overnight, the reaction mixture was diluted with EtOAc, washed with brine, dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was purified by flash chromatography (Isco 40 g column eluting with 0-15% methanol/DCM). The resulting solid was lyophilized from acetonitrile/water to give the title compound (22 mg, 70%) as a white solid. 1H NMR (CD3OD, 1:1 mixture of amide rotamers) δ 8.62 (s, 1H), 8.14-7.93 (m, 6H), 7.64-7.57 (m, 2H), 7.40-6.87 (m, 9H), 4.87-4.00 (m, 9H), 3.70-3.67 (m, 2H), 3.12-2.35 (m, 4H), 1.07-0.88 (m, 4H), 0.56-0.52 (m, 3H); MS(ESI+) m/z 789.5 (M+H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09346795B2 |
|---|
| Source dataset | uspto-grants-2016_05 |
|---|
| ORD ID | ord-74d7389b28ae4c37b3498d36d2981b1d |
|---|
| Source note | uspto-grants-2016_05 |
|---|